Aytu BioScience (NASDAQ: AYTU) reported Q1 EPS of ($0.06), $0.18 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $27.66 million versus the consensus estimate of $24.8 million.

For earnings history and earnings-related data on Aytu BioScience (AYTU) click here.